No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DK Delek US
- 29.500
- -0.260-0.87%
Close Apr 24 16:00 ET
- 29.500
- 0.0000.00%
Post 17:34 ET
1.89BMarket Cap98.33P/E (TTM)
29.690High29.265Low695.03KVolume29.570Open29.760Pre Close20.51MTurnover1.11%Turnover Ratio98.33P/E (Static)64.02MShares33.60052wk High2.23P/B1.84BFloat Cap18.65652wk Low0.93Dividend TTM62.47MShs Float52.885Historical High3.14%Div YieldTTM1.43%Amplitude2.074Historical Low29.509Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Piper Sandler Sticks to Their Hold Rating for Delek US Holdings (DK)
Express News | Delek US Holdings Inc : Raymond James Raises Target Price to $34 From $32
Express News | Delek US Holdings Inc : TD Cowen Cuts Target Price to $27 From $32
Delek Logistics Partners, LP Announces Pricing of Offering of $200 Million of Additional 8.625% Senior Notes Due 2029
Delek Logistics Partners, LP (NYSE:DKL) ("Delek Logistics") announced today that it, along with Delek Logistics Finance Corp., a subsidiary of Delek Logistics (together with Delek Logistics, the "Issuers"), priced an
Delek Logistics Partners, LP Announces Proposed Offering of $200 Million of Additional 8.625% Senior Notes Due 2029
Delek Logistics Partners, LP (NYSE:DKL) ("Delek Logistics") announced today that it, along with Delek Logistics Finance Corp., a subsidiary of Delek Logistics (together with Delek Logistics, the "Issuers"), intends to
Delek US Is Maintained at Sector Perform by Scotiabank
Delek US Is Maintained at Sector Perform by Scotiabank
Comments
Delek US Holdings' low P/S ratio is due to predicted revenue decline. Investors see no significant potential for revenue growth to justify a higher P/S ratio. Without major changes, a significant stock price increase is unlikely. The company's weak outlook is pressuring the shares downwards.
Benign Growth For Delek US Holdings, Inc. (NYSE:DK) Underpins Its Share PriceThe board of Delek US Holdings expresses positive sentiment towards the appointment of Ms. Benson, highlighting her experience in risk management, capital markets, and green energies as instrumental for the company's strategic initiatives.
Delek's lower Return on Equity (ROE) coupled with high debt levels make it less attractive for investment. Investors should also consider profit growth rates and market expectations before investing in Delek or similar companies.
ColumnsToday's pre-market stock movers: BBIO, LZB, ORA, DOW and more
Gainers:
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $La-Z-Boy(LZB.US$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US$)
• $Ikena Oncology(IKNA.US$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
8
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg